Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara.

Ítems similars

• Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity.
  per: Sharpe, S, et al.
  Publicat: (2001)
• Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.
  per: Hanke, T, et al.
  Publicat: (1999)
• Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen.
  per: Allen, T, et al.
  Publicat: (2000)
• Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara.
  per: Smith, C, et al.
  Publicat: (2005)
• Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
  per: Hanke, T, et al.
  Publicat: (1998)